ReviewFrontiers in immunology2023

The effect of combining PD-1 agonist and low-dose Interleukin-2 on treating systemic lupus erythematosus.

Bing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.